Open House Biologics Rebate Contracts 2022-22 Tender

• Country: Germany
• Summary: Open House Biologics Rebate Contracts 2022-22 - Peginterferon Beta-1A
• DET Ref No: 76351380
• Deadline: 31 Jan 2025
• Financier: Self Financed
• Purchaser Ownership: Government
• Tender Value: Refer Document
• Notice Type: Tender
• Document Ref. No.: 705970-2022
• Purchaser's Detail:
  Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.

  Login to see details
• Description:
• The health insurers involved are pursuing the goal of concluding discount agreements for the active ingredient peginterferon beta-1a with all suitable pharmaceutical companies in accordance with Section 130a (8) SGB V. The contract is concluded as part of the open-house biologics procedure of the health insurance companies involved:
  Individual VeThere are no negotiations about the content of the contract, uniform conditions apply. The cash registers involved do not guarantee individual contractual partners any exclusivity. The contract term is a maximum of 24 months starting on February 1st, 2023. The contract ends no later than January 31, 2025, regardless ofgig from the date of conclusion of the contract.
  If the patent expires before January 31, 2025, the contract ends automatically at the end of the month in which the patent expires.
  All further information can be found in the participation and contract documents.
  Doc Title: Pharmaceutical products
  Contract Type: Supplies
• Documents:

 Tender Notice